http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2337049-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86d5ed9cdf8be19c83262f867b7531b9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 |
| filingDate | 1999-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a4c934a11d474b8009ad75949eef15d |
| publicationDate | 2000-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2337049-A1 |
| titleOfInvention | New pharmaceutical preparation and method |
| abstract | A new pharmaceutical preparation comprising at least one amine, or an analogue, a precursor or a pharmaceutically acceptable salt thereof capable of being taken up by and stored in mast cells and released therefrom upon binding of an allergen to a receptor on the mast cells. This pharmaceutical preparation is intended for treatment and/or prevention of allergy. A method for treatment and/or prevention of allergy, comprising administration to a patient of an effective amount of at least one amine, or an analogue, a precursor or a pharmaceutically acceptable salt thereof that is taken up by and stored in the patient's mast cells, and released therefrom upon binding of an allergen to a receptor on the mast cells. The above mentioned substance must not be histamine or a substance with histaminergic effects. It is preferably a biogenic monoamine, or an analogue, a precursor or a pharmaceutically acceptable salt thereof, and most preferably 5-HTP or a derivative thereof. |
| priorityDate | 1998-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.